¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pigmented basal cell carcinoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
¿µ¹® nerve cell ÇÑ±Û ½Å°æ¼¼Æ÷
¼³¸í   
  ½Å°æ¼¼Æ÷´Â ¿Ã¹Ù¸¥ ½Å°æÀü´ÞÀ» À§ÇÑ °¢ ºÎºÐº°·Î ³ª´µ¾îÁ® ÀÖ´Ù. ½Å°æ¼¼Æ÷¿¡¼­´Â ÀüÇØÁ®¿À´Â ÀÚ±ØÀ» Àü±âÀûÀΠ½ÅÈ£·Î ¹Ù²î¾î º¸³»°Å³ª ¹Þ°Ô µÈ´Ù. ÀÌ·± Àü±âÀûÀΠÇö»óÀº °¢ ½Å°æ¼¼Æ÷³»¿¡ Á¸ÀçÇϴ °¢ ÀÌ¿Âä³Î(ion channel: ionÀ̶õ ³ªÆ®·ý, Ä®·ý µîÀ» ÁöĪÇϴ ¸»µé·Î½á, À̵éÀÌ ¼¼Æ÷¸·¿¡ ÀÇÇØ ³ª´µ¾îÁú ¶§ »ý±â´Â Àü¾ÐÂ÷°¡ Àü±âÀû ÀÚ±ØÀ» ÀÏÀ¸Å°°í À¯ÁöÇϴµ¥ °áÁ¤ÀûÀΠ¿ªÇÒÀ» ÇÑ´Ù)µéÀÇ ÀÛ¿ë¿¡ ÀÇÇØ ÀÌ·ç¾îÁö°Ô µÈ´Ù.
¿µ¹® glia cell ÇÑ±Û ¾Æ±³¼¼Æ÷
¼³¸í   
  ½Å°æ¼¼Æ÷ »çÀÌ¿¡¼­ ±×¹°±¸Á¶¸¦ ÀÌ·ç¸ç À̸¦ ÁöÁöÇϴ Á¶Á÷. ½Å°æ¾Æ±³¼¼Æ÷´Â ½Å°æ¸ð¼¼Æ÷¿Í °¥¶óÁø ¾Æ±³¸ð¼¼Æ÷°¡ ´Ù½Ã ¿©·¯ ÇüÅ·ΠºÐÈ­-¼ºÀåÇÑ °ÍÀÌ´Ù. ³ú½ÇÀ̳ª Ã´¼öÁ߽ɰüÀÇ º®À» µ¤°í ¿øÁÖ»ó ¶Ç´Â ÀÔ¹æÇüÀ̸ç, Ãʱ⿡´Â À¯¸®¸é¿¡ ¼¶¸ð°¡ ÀÖ´Ù. ´ëÇü¼¼Æ÷´Â º°³ú½Ç¸·¼¼Æ÷´Â ¾Æ±³¼¼Æ÷¶ó°í Çϸç, ½Å°æ¼¼Æ÷³ª ½Å°æ¼¶À¯ »çÀÌ¿¡ »êÀçÇÑ´Ù. ±× ¿Ü¿¡ Èñ¼Òµ¹±â¾Æ±³¼¼Æ÷µµ Æ÷ÇԵȴÙ.
¿µ¹® reserve cell ÇÑ±Û ¿¹ºñ¼¼Æ÷
¼³¸í   
  ÀϹÝÀûÀ¸·Î »óÇÇÁ¶Á÷¿¡¼­ À̹̠ÀÖ´ø »óÇǼ¼Æ÷°¡ ¼Õ»óÀ» ¹Þ¾Æ »ç¸êÇϸ頸ŲãÁö´Â ±× ¹Ø¿¡ Àִ ¹ÌºÐÈ­¼¼Æ÷ ¿¹¸¦ µé¸é, ±â°üÁö ³»Ç¥¸éÀ» µ¤´Â ÁßÃþ ¿øÁÖ »óÇÇÀÇ ±âÀú¿¡ Àִ ÀÛÀº ¹ÌºÐÈ­ »óÇÇ ¼¼Æ÷.
¿µ¹® stem cell ÇÑ±Û Áٱ⼼Æ÷, °£¼¼Æ÷
¼³¸í   
  Àڱ⠺¹Á¦¸¦ ÇÏ¿© ÀÚ½ÅÀ» Á¸¼Ó½ÃŰ¸é¼­ ÇÑÆíÀ¸·Î´Â Áõ½Ä°ú ºÐÈ­¸¦ ÇÏ¿© »õ·Î¿î ¼¼Æ÷¸¦ Çü¼ºÇϴ ¼¼Æ÷·Î¼­ Á¶Ç÷Áٱ⼼Æ÷°¡ ´ëÇ¥ÀûÀÌ´Ù. Á¶Ç÷Áٱ⼼Æ÷´Â °ñ¼ö¿¡ Àִ ¼¼Æ÷·Î¼­ ¸ðµç Ç÷±¸¼¼Æ÷°¡ ¿©±â¿¡¼­ ºÐÈ­µÇ¾î ¹ß»ýÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • basal diet
    1. ±âÃʽĻç 2. ±âÃÊÀ½½Ä
  • basal ganglia
    ¹Ù´ÚÇÙ, ±âÀúÇÙ
  • basal iridectomy
    ¹Ù´ÚȫüÀýÁ¦(¼ú), ±âÀúȫüÀýÁ¦(¼ú)
  • basal lamina
    1. ¹Ù´ÚÆÇ, ±âÀúÆÇ 2. Ä¡¹ÐÆÇ
  • basal layer
    ¹Ù´ÚÃþ, ±âÀúÃþ
  • basal medium
    ±âÃʹèÁö
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • basal metabolism
    ±âÃÊ´ë»ç
  • basal nuclei
    ¹Ù´ÚÇÙ, ±âÀúÇÙ
  • basal plate
    ¹Ù´ÚÆÇ, ±âÀúÆÇ
  • basal seat
    ÀÇÄ¡ÁöÁöÁ¶Á÷
  • basal segment
    ¹Ù´Ú±¸¿ª
  • basal segmental bronchus
    ¹Ù´Ú±¸¿ª±â°üÁö
  • basal state
    ±âÃÊ»óÅÂ
  • basal striated border
    ¹Ù´ÚÁÙ¹«´Ì°¡ÀåÀÚ¸®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • killer cell
    »ìÇØ¼¼Æ÷
  • Kupffer's cell
    º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
  • mast cell
    ºñ¸¸¼¼Æ÷
  • mesenchymal cell
    Áß°£¿±¼¼Æ÷
  • mesothelial cell
    ÁßÇǼ¼Æ÷
  • mother cell
    ¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
  • neuroendocrine cell
    ½Å°æ³»ºÐºñ¼¼Æ÷
  • packed red blood cell
    ³óÃàÀûÇ÷±¸
  • parietal cell
    º®¼¼Æ÷
  • perivascular cell
    Ç÷°üÁÖÀ§¼¼Æ÷
  • plasma cell
    ÇüÁú¼¼Æ÷
  • polynucleated cell
    ¹µÇÙ¼¼Æ÷
  • prickle cell
    °¡½Ã¼¼Æ÷
  • principal cell
    ÁÖ¼¼Æ÷, À¸¶ä¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • basal medium
    ±âº»¹èÁö, ±âÃʹèÁö
  • basal nuclei
    ¹Ù´ÚÇÙ, ±âÀúÇÙ
  • basal plate
    ¹Ù´ÚÆÇ, ±âÀúÆÇ
  • basal seat
    ÀÇÄ¡ÁöÁöÁ¶Á÷
  • basal segment
    ¹Ù´Ú±¸¿ª
  • basal state
    ±âÃÊ»óÅÂ
  • basal turn
    ±âÀúȸÀü, ¹Ù´Úµ¹±â
  • basal blood pressure
    ±âÀúÇ÷¾Ð
  • basal body temperature
    ±âÃÊü¿Â
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • basal segmental bronchus
    ¹Ù´Ú±¸¿ª±â°üÁö
  • basal striated border
    ¹Ù´ÚÁÙ¹«´Ì°¡ÀåÀÚ¸®
  • enamel basal lamina
    »ç±âÁú¹Ù´ÚÆÇ
  • acinar carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
  • adenocystic carcinoma
    (¢¡adenoid cystic carcinoma) »ù³¶¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • pigmented reticulated dermatosis
    »ö¼Ò¸Á»óÇüÇǺÎÁõ(ßäáÈàõØÑßÒû¡ù«Ý±ñø)
  • pigmented villo-nodular synovitis
    »ö¼ÒÄ§ÂøÀ¶¸ð¼Ò°áÀý¼º Ȱ¸·¿°(ßäáÈöØó·ëÖÙ¾á´Ì¿ï½àõ üÁدæú)
  • pretibial pigmented patch
    °æ°ñ¾Õ »ö¼Ò¼º ¹Ý
  • Meibomian gland carcinoma
    ¸¶À̺½¼± ¾Ï(Á¾)
  • acinar carcinoma
    ¼±¹æ¾ÏÁ¾(¼±¹æ¾ÏÁ¾).
  • adenocystic carcinoma
    ¼±³¶Á¾¼º¾Ï
  • adenoid cystic carcinoma
    ¼±¾ç³¶¼º¾ÏÁ¾(àÍåÆÒ¥àõäßðþ)
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • adnexal carcinoma
    ºÎ¼Ó±â(ݾáÕÐï) ¾Ï
  • apocrine gland carcinoma
    ¾ÆÆ÷Å©¸°¼±(~ àÍ) ¾Ï(Á¾)(äß(ðþ))
  • arsenical carcinoma
    ºñ¼Ò¼º(Ý÷áÈàõ) ¾Ï(Á¾)
  • gastric carcinoma
    À§¾ÏÁ¾(êÖäßðþ)
  • glandular carcinoma
    ¼±¾ÏÁ¾(¼±¾ÏÁ¾).
  • hepatocellular carcinoma
    °£¼¼Æ÷¼º ¾Ï
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾(ÊÜá¬øàäßðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • pigmented cast
    »ö¼Ò¿øÁÖ(ßäáÈê­ñº)
  • pigmented cosmetic dermatitis
    »ö¼ÒÄ§Âø È­Àåǰ ÇǺο°
  • pigmented epithelium
    »ö¼Ò»óÇÇ(ßäáÈß¾ù«).
  • pigmented epithelium
    »ö¼Ò»óÇÇ
  • pigmented layer
    »ö¼Ò»óÇÇÃþ(¡­ß¾ù«öµ).
  • pigmented layer
    »ö¼Ò»óÇÇÃþ(¡­ß¾ù«öµ).
  • pigmented layer
    »ö¼ÒÃþ
  • pigmented liver
    »ö¼ÒÄ§Âø°£(ßäáÈàõöØó·ÊÜ)
  • pigmented mole
    »ö¼Ò¸ð¹Ý(ßäáÈÙ½Úè)
  • pigmented nevi
    »ö¼Ò¼º ¸ð¹Ý(ßäáÈàõ Ù½Úè)
  • pigmented nevus
    »ö¼Ò¼º ¸ð¹Ý(ßäáÈàõÙ½Úè)
  • pigmented nevus
    »ö¼Ò¸ð¹Ý
  • pigmented purpuric lichenoid dermatitis
    »ö¼Ò¼º Àڹݼº ż±¾ç ÇǺο°(ßäáÈàõ í¹Úèàõ ÷ÄàÈåÆ ù«Ý±æú)
  • pigmented purpuric lichenoid dermatitis
    »ö¼Ò¼º Àڹݼº ż±¾ç ÇǺο°(¡­í¹ Úèàõ÷ÄàÈåÆù«Ý±æú)
  • pigmented reticulated dermatosis
    »ö¼Ò¸Á»óÇüÇǺÎÁõ(ßäáÈàõØÑßÒû¡ù«Ý±ñø)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Basal lamina
    ¹Ù´ÚÆÇ
    [¿¾ ¿ë¾î] ±âÀúÆÇ
  • Basal plate
    ¹Ù´ÚÆÇ
    [¿¾ ¿ë¾î] ±âÀúÆÇ
  • Basal plate
    ¹Ù´ÚÆÇ
    [¿¾ ¿ë¾î] ÀúÆÇ
  • Basal membrane of semicircular duct
    ¹Ý°í¸®°ü¹Ù´Ú¸·
    [¿¾ ¿ë¾î] ¹Ý±Ô°ü±âÀú¸·
  • Enamel basal lamina
    »ç±âÁú¹Ù´ÚÆÇ
    [¿¾ ¿ë¾î] ¿¡³ª¸á¸ðÁú±âÀúÆÇ
  • Inferior basal vein
    ¾Æ·¡¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇÏÆóÀúÁ¤¸Æ
  • Medial basal branch
    ¾ÈÂʹٴڰ¡Áö
    [¿¾ ¿ë¾î] ³»ÃøÆóÀúµ¿¸Æ
  • Medial basal segment
    ¾ÈÂʹٴڱ¸¿ª
    [¿¾ ¿ë¾î] ³»ÃøÆóÀú±¸
  • Medial basal segmental bronchus
    ¾ÈÂʹٴڱ¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ³»ÃøÆóÀúÁö
  • Anterior basal branch
    ¾Õ¹Ù´Ú°¡Áö
    [¿¾ ¿ë¾î] ÀüÆóÀúµ¿¸Æ
  • Anterior basal branch
    ¾Õ¹Ù´Ú°¡Áö
    [¿¾ ¿ë¾î] ÀüÆóÀúÁ¤¸Æ
  • Anterior basal segment
    ¾Õ¹Ù´Ú±¸¿ª
    [¿¾ ¿ë¾î] ÀüÆóÀú±¸
  • Anterior basal segmental bronchus
    ¾Õ¹Ù´Ú±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ÀüÆóÀúÁö
  • Anterior basal root
    ¾Õ¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÀüÆóÀúÁ¤¸Æ
  • Common basal vein
    ¿Â¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÆóÀúÁ¤¸Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • established cell line
    ¼ö¸³ ¼¼Æ÷ÁÖ (â§Ø¡á¬øàñ»)
  • feeder cell
    °ø±ÞÀÚ¼¼Æ÷ (ÍêÐåíºá¬øà)
  • flow cell
    È帧 ½Ç(ãø)
  • founder cell
    ½ÃÁ¶ ¼¼Æ÷(ã·ðÓá¬øà)
  • germ cell
    ¹è¼¼Æ÷(ÛÏá¬øà)
  • germinal cell
    ¹è¾Æ¼¼Æ÷(ÛÏä´á¬øà)
  • glial cell
    ½Å°æ±³¼¼Æ÷(ãêÌèÎïá¬øà)
  • half-cell
    ¹Ý½Ç(Úâãø)
  • helper T cell
    µµ¿òÀÌ T ¼¼Æ÷(á¬øà)
  • host-cell reactivation
    ¼÷ÁÖ ¼¼Æ÷ ÀçȰ¼ºÈ­(âÖñ«á¬øàî¢üÀàõûù)
  • hybrid cell
    Æ¢±â¼¼Æ÷(á¬øà)
  • I-cell disease
    I-¼¼Æ÷ Áúȯ(á¬øàòðü´)
  • immune competent cell
    ¸é¿ª Àû°Ý ¼¼Æ÷(Øóæ¹îêÌ«á¬øà)
  • immunocompetent cell
    ¸é¿ªÀû°Ý¼¼Æ÷(Øóæ¹îêÌ«á¬øà)
  • immunologically competent cell
    ¸é¿ª Àû°Ý ¼¼Æ÷(Øóæ¹îêÌ«á¬øà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • granular cell myoblastoma
    °ú¸³¼¼Æ÷±Ù¸ð¼¼Æ÷Á¾
  • granulosa cell
    °ú¸³¸·¼¼Æ÷
  • granulosa cell tumor
    °ú¸³¸·¼¼Æ÷Á¾¾ç
  • islet cell
    µµ¼¼Æ÷
  • islet cell adenoma
    Ãéµµ¼¼Æ÷¼±Á¾
  • Langerhans' cell
    ¶û°Ô¸£Çѽº¼¼Æ÷
  • Langhans' glant cell
    ¶û±×Çѽº°Å¼¼Æ÷
  • large cell
    ´ë¼¼Æ÷
  • lymphoid cell
    ¸²ÇÁ¾ç¼¼Æ÷, ¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ±¸¾ç¼¼Æ÷
  • mast cell
    ºñ¸¸¼¼Æ÷
  • mastoid air cell
    À¯µ¹ºÀ¼Ò
  • mastoid cell
    À¯(¾ç)µ¹(±â)ºÀ¼Ò
  • nerve cell
    ½Å°æ¼¼Æ÷
  • neuroepithelial cell
    ½Å°æ»óÇǼ¼Æ÷
  • neuroglial cell
    ½Å°æ¾Æ±³¼¼Æ÷, ½Å°æ±³¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CCL carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca...
LCC lactose coliform count; left circumflex coronary (artery); left common carotid; left coronary cusp; ...
MCT manual cervical traction; mean cell thickness; mean cell threshold; mean circulation time; mean corp...
RCA red cell agglutination; relative chemotactic activity; renal cell carcinoma; right carotid artery; r...
sq cell ca squamous cell carcinoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
NPE non-pigmented
NPE non-pigmented ciliary epithelial
PE pigmented epithelium
B Basal
BAO Basal
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • basal crest
    ¹Ù´Ú ´É¼±
  • basal dose
    ±âº» ¼±·®
  • basal endometrium
    ¹Ù´Ú ÀڱüӸ·
  • basal epithelial layer
    ±âÀú »óÇÇ Ãþ
  • basal foot
    ¹Ù´Ú ¹ß
  • basal ganglia
    ±âÀú ÇÙ, ´ë³ú ±âÀúÇÙ
    ´ë³ú ¹Ý±¸ ¼Ó¿¡ À§Ä¡ÇÑ È¸»öÁúÀÇ ½Å°æÇÙ ÁýÇÕü. ±â´ÉÀº ÀÚ¼¼¿Í ¼öÀÇÀû ¿îµ¿À» Á¶ÀýÇÑ´Ù.
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • basal hypothalamus
    ½Ã»ó ÇϺΠ±âÀú
  • basal lamina
    ±âÀú ÆÇ
    1. ¹è °æ°è±¸ÀÇ º¹Ãø¿¡ ÀÖ´Â ½Å°æ°üÀÇ Á¿ì ÇÑ ½ÖÀÇ Á¾´ë·Î¼­, ô¼öÀüÁÖ È¸¹éÁÖ¿Í ³úÀÇ ¿îµ¿ ÁßÃß·Î ¹ß´ÞÇÑ´Ù. 2. »óÇÇ ¼¼Æ÷µéÀÌ °áÇÕ Á¶Á÷°ú ¸Â´ê¾Æ ÀÖ´Â °÷¿¡ Á¸ÀçÇÏ¸ç »óÇÇÀÇ ¸¶´Ú¸é ¶Ç´Â ±ÙÀ°, ¸ð¼¼Ç÷°ü, Áö¹æ ¼¼Æ÷ ¹× ½Å°æÃÊ ¼¼Æ÷ µîÀ» µÑ·¯½Î°í ÀÖ´Â ÆÇ ¸ð¾çÀÇ ¼¼Æ÷¹Û ±¸Á¶. µÎ²²°¡ ´Ù¾çÇϸç laminin °°Àº glyco
  • basal lamina of choroid
    ¸Æ¶ô¸· ±âÀúÆÇ
  • basal layer of endometrium
    ÀڱüӸ· ¹Ù´ÚÃþ
  • basal medium
    ±âÃÊ ¹èÁö
  • basal membrane of semicircular canal
    ¹Ý±Ô°ü ±âÀú¸·, ¹Ý°í¸®°ü ¹Ù´Ú ¸·
  • basal metabolic rate
    ±âÃÊ ´ë»çÀ²
    ½Ä»ç ÈÄ ÀÏÁ¤ ½Ã°£ÀÌ Áö³ª°í ³ª¼­ÀÇ ¾ÈÁ¤ »óÅ¿¡¼­ÀÇ »ê¼Ò ¼Òºñ ¼Óµµ.
  • basal narcosis
    ±âÃÊ ¸¶Ãë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
carcinoma, squamous cell A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present.
(12 Dec 1998)
carcinoma, transitional cell A malignant neoplasm derived from transitional epithelium, occurring chiefly in the urinary bladder, ureters or renal pelves (especially if well differentiated), frequently papillary. Transitional cell carcinomas are graded 1 to 3 or 4 according to the degree of anaplasia, grade 1 appearing histologically benign but being liable to recurrence.
(12 Dec 1998)
giant cell carcinoma <tumour> A malignant epithelial neoplasm characterised by unusually large anaplastic cells.
(05 Mar 2000)
giant cell carcinoma of thyroid gland A rapidly progressive undifferentiated carcinoma observed in the thyroid gland, characterised by numerous, unusually large, anaplastic cells derived from glandular epithelium of the thyroid gland.
(05 Mar 2000)
renal cell carcinoma <oncology, tumour> The most common form of kidney cancer which occurs when the cells lining the renal tubule undergo cancerous changes. There are approximately 18,000 new cases of renal cell carcinoma (hypernephroma) per year in the U.S. With about 8,000 deaths annually.
Smoking is considered a major risk factor. Kidney dialysis patients are at increased risk for the development of hypernephroma. Family history for renal cell carcinoma is also considered a risk factor.
Symptoms include haematuria, flank pain, abdominal pain, back pain, weight loss and abdominal swelling.
(27 Sep 1997)
clear cell carcinoma of kidney <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
Hurthle cell carcinoma A neoplasm of the thyroid gland composed of polyhedral acidophilic cells, thought by some to be oncocytes; it may be benign or malignant, the behaviour of the latter depending on the general microscopic pattern, whether follicular, papillary, or undifferentiated.
See: Hurthle cell adenoma.
Synonym: Hurthle cell carcinoma.
(05 Mar 2000)
signet-ring cell carcinoma <tumour> A poorly differentiated adenocarcinoma composed of cells with a cytoplasmic droplet of mucus that compresses the nucleus to one side along the cell membrane; arises most frequently in the stomach, occasionally in the large bowel or elsewhere.
(05 Mar 2000)
small cell carcinoma <oncology, tumour> Common malignant neoplasm of bronchus.
Cells of the tumour have endocrine like characteristics and may secrete one or more of a wide range of hormones, especially regulatory peptides like bombesin.
(18 Nov 1997)
spindle cell carcinoma <tumour> A carcinoma composed of elongated cells, frequently a poorly differentiated squamous cell carcinoma which may be difficult to distinguish from a sarcoma.
Synonym: sarcomatoid carcinoma.
(05 Mar 2000)
squamous cell carcinoma <oncology, tumour> A malignant growth originating from a squamous cell. This form of cancer can be seen on the skin, lips, inside the mouth, throat or oesophagus.
(27 Sep 1997)
infiltrating ductal cell carcinoma <oncology, tumour> A cancer that begins in the mammary glands and has spread to areas outside the gland.
(13 Nov 1997)
oat cell carcinoma <tumour> An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with very scanty cytoplasm; this carcinoma and small round cell carcinoma's comprise over one-third of carcinoma's of the lung.
Synonym: small cell carcinoma.
(05 Mar 2000)
transitional cell carcinoma Cancer that develops in the lining of the renal pelvis. This type of cancer also occurs in the ureter and the bladder.
(12 Dec 1998)
fibrolamellar liver cell carcinoma <tumour> Primary hepatic carcinoma in which malignant hepatocytes are intersected by fibrous lamellated bands.
Synonym: oncocytic hepatocellular tumour.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • red blood cell(corpuscle)
    ÀûÇ÷±¸
  • red cell
    =REC BLOOD CELL
  • solar battery(cell)
    žç ÀüÁö
  • storage cell
    ÃàÀüÁö;±â¾ï ´ÜÀ§
  • voltaic cell
    ÀüÁö
  • wet cell
    ½ÀÀüÁö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á